Allianz Asset Management GmbH - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$3,806,000
-10.0%
112,011
-3.0%
0.00%
-25.0%
Q2 2021$4,227,000
-21.2%
115,459
-3.5%
0.00%
-20.0%
Q1 2021$5,365,000
-0.4%
119,641
+26.7%
0.01%0.0%
Q4 2020$5,388,000
+26.9%
94,416
+14.1%
0.01%0.0%
Q3 2020$4,245,000
-19.9%
82,752
-6.7%
0.01%
-16.7%
Q2 2020$5,297,000
+55.6%
88,701
+7.3%
0.01%
+20.0%
Q1 2020$3,405,000
+1.9%
82,689
+54.0%
0.01%
+66.7%
Q4 2019$3,343,000
+526.0%
53,711
+237.0%
0.00%
+200.0%
Q3 2019$534,000
+42.8%
15,940
-3.9%
0.00%
Q2 2019$374,00016,5910.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders